MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member

<p>MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicines ROCKVILLE, Md., Nov. 16, 2023 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing [&#8230;]</p>
<p>The post <a href="https://forextv.com/top-news/maxcyte-joins-the-alliance-for-mrna-medicines-amm-as-a-founding-member/">MaxCyte Joins the Alliance for mRNA Medicines (AMM) as a Founding Member</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>